Kintor Pharmaceutical Limited

SEHK:9939 Stok Raporu

Piyasa değeri: HK$476.3m

Kintor Pharmaceutical Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Kintor Pharmaceutical's earnings have been declining at an average annual rate of -22.2%, while the Biotechs industry saw earnings growing at 31.7% annually. Revenues have been declining at an average rate of 85.7% per year.

Anahtar bilgiler

-22.2%

Kazanç büyüme oranı

-12.9%

EPS büyüme oranı

Biotechs Sektör Büyümesi11.0%
Gelir büyüme oranı-85.7%
Özkaynak getirisi-235.0%
Net Marjn/a
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Is Kintor Pharmaceutical (HKG:9939) Using Debt In A Risky Way?

Oct 07
Is Kintor Pharmaceutical (HKG:9939) Using Debt In A Risky Way?

Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Nov 16
Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Apr 28
Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Dec 06
Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Is Kintor Pharmaceutical (HKG:9939) Using Debt Sensibly?

Sep 01
Is Kintor Pharmaceutical (HKG:9939) Using Debt Sensibly?

Kintor Pharmaceutical Limited (HKG:9939) Insiders Increased Their Holdings

Feb 17
Kintor Pharmaceutical Limited (HKG:9939) Insiders Increased Their Holdings

What Kind Of Investors Own Most Of Kintor Pharmaceutical Limited (HKG:9939)?

Dec 23
What Kind Of Investors Own Most Of Kintor Pharmaceutical Limited (HKG:9939)?

Gelir ve Gider Dağılımı

Kintor Pharmaceutical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SEHK:9939 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 240-92072814
31 Mar 240-99184876
31 Dec 230-1,06196939
30 Sep 230-854116735
30 Jun 230-648136532
31 Mar 230-801144680
31 Dec 220-954153828
30 Sep 2217-995145887
30 Jun 2234-1,035138947
31 Mar 2234-938128857
31 Dec 2134-842118768
30 Sep 2117-740116615
30 Jun 210-639114463
31 Mar 210-573100396
31 Dec 200-50886329
30 Sep 200-41963301
30 Jun 200-33039273
31 Mar 200-28130243
31 Dec 190-23321214
31 Dec 181-1082493
31 Dec 170-46500
30 Sep 170-41440
30 Jun 170-35390
31 Mar 171-45490
31 Dec 161-54600
31 Dec 150-11140

Kaliteli Kazançlar: 9939 is currently unprofitable.

Büyüyen Kar Marjı: 9939 is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 9939 is unprofitable, and losses have increased over the past 5 years at a rate of 22.2% per year.

Büyüme Hızlandırma: Unable to compare 9939's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: 9939 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (5.5%).


Özkaynak Getirisi

Yüksek ROE: 9939 has a negative Return on Equity (-235%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin